Chapter 1. IN VITRO LUNG MODEL MARKET– Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. IN VITRO LUNG MODEL MARKET– Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-110 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. IN VITRO LUNG MODEL MARKET– Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. IN VITRO LUNG MODEL MARKET- Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. IN VITRO LUNG MODEL MARKET- Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. IN VITRO LUNG MODEL MARKET– By Type
6.1. 2D Models
6.2. 3D Models
Chapter 7. IN VITRO LUNG MODEL MARKET– By Application
7.1. Drug Screening and Testing
7.2. Toxicity Testing
7.3. 3D Printing
7.4. Research
Chapter 8. IN VITRO LUNG MODEL MARKET– By End User
8.1. Pharmaceutical & Biotechnology Companies
8.2. Academic and Research Institutes
8.3. Contract Research Organizations
8.4. Others
Chapter 9. IN VITRO LUNG MODEL MARKET– By Region
9.1. North America
9.2. Europe
9.3. The Asia Pacific
9.4. Latin America
9.5. Middle-East and Africa
Chapter 10. IN VITRO LUNG MODEL MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1. Company 1
10.2. Company 2
10.3. Company 3
10.4. Company 4
10.5. Company 5
10.6. Company 6
10.7. Company 7
10.8. Company 8
10.9. Company 9
10.10. Company 10
2850
5250
4500
1800